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Abstract:  
Introduction: Various implant surface treatments currently available are focusing on 
decontamination and inhibition of microbial adherence to implant surfaces, thus attempting 
to prevent peri-implantitis. Laser therapy has shown potential for treating such conditions by 
safely irradiating titanium surfaces without altering the delicate titanium microstructure, 
important for osseointegration. The aim of this study was to perform a narrative literature 
review and analyse current evidence available on the effectiveness of laser decontamination 
of implant surfaces and treatment of peri-implantitis. 
Method: The Electronic databases Medline (via PubMed and OvidSp) and Trip were 
systematically searched.   
Results:  Eight studies have been reviewed and treatment outcomes for Er:YAG (Erbium-
Doped Yttrium Aluminium Garnet), Carbon Dioxide Lasers (CO2 lasers), Gallium-aluminium-
arsenide (GaAlAs) diode lasers, Nd:YAG (Neodymium-doped yttrium aluminium garnet) and 
photodynamic therapy have been analysed. Despite inconsistencies among studies in terms 
of study design, positive short-term therapeutic effects have been observed throughout all 
investigated studies.  
Conclusion: Future research needs to focus on longer follow-up periods, synchronizing user 
settings by implementing guidance on laser power and application, limiting the use of 
adjunctive interventions and consistent evaluation of clinical outcome variables throughout 
studies. 
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Introduction 
A variety of laser settings enables employment in various areas of dentistry. One of them is 
the rapidly evolving area of implantology. Tissue ablation and reduction in bacterial 
contamination of implant surfaces, soft tissue management and treatment of peri-implantitis 
(PI) are of special interest to ultimately improve implant longevity.1  
The most common dental implant failure is due to PI and its incidence ranges from 12%-43% 
of dental implant sites.2 Implant removal rates of 8-50% are also attributable to PI.3 PI can be 
defined as an inflammatory process affecting peri-implant bone post-osseointegration to the 
functional implant surface, that ultimately results in bone loss.4  Its risk factors include plaque, 
poor oral hygiene, periodontal disease, diabetes, alcohol consumption and smoking.3  
Most commercial dental implants are made of titanium or titanium alloys. To increase surface 
area and enhance osseointegration, a range of surface modifications are available such as 
sandblasting, plasma spraying and anodizing etching.3 PI was found to occur more frequently 
around implants with roughened surfaces as this provides microorganisms with a greater 
surface area to adhere to.5 The formation of biofilms on implant surfaces can induce 
inflammation and ultimately bone loss.3  
Current decontamination protocols suggest plastic curettage, chlorhexidine digluconate, 
iodine as well as local and systemic antibiotics for titanium surface decontamination. The use 
of ultrasonics and metal instrumentation is contraindicated due to potential induction of 
surface alterations of the implant surface.2 Using certain lasers with appropriate power 
settings for debridement, avoids mechanical interference and destruction of the micro-
texture of the implant surface.6   
  
A variety of lasers for the decontamination of implant surfaces are available. These include 
Nd:YAG (Neodymium-doped yttrium aluminium garnet), Carbon dioxide (CO2), Gallium-
aluminium-arsenide (GaAlAs) diode, Chromium-doped yttrium-scandium-gallium-garnet and 
Erbium-doped yttrium–aluminium–garnet (Er:YAG). However, studies found the Er:YAG to be 
the most consistent.7 The Er:YAG laser has proven to be effective in the removal of plaque 
and calculus on contaminated abutments. This is made possible through emitting a 
wavelength of 2.94 μm that is highly absorbed in water.4 Excellent results in periodontal 
therapy could be achieved in terms of bactericidal and detoxification effects. These results 
suggest a potential utilisation of the Er:YAG laser in the removal of biofilms and thus PI 
therapy.4 
The aim of this study was to perform a comprehensive literature review of the most relevant 
papers published on the use of lasers in dental implant surface treatment in patients with PI 
and to determine its effectiveness of decontamination as well as viability of treating PI. 
 
Materials and Methods 
PICO: This is a useful tool for asking a focussed clinical question and is an acronym for: 
Population, Intervention, Comparison and Outcome. In this mini systematic review, our PICO 
question was: “For patients suffering from peri-implantitis (P), is laser decontamination of 
implant surfaces (I), compared to traditional non-surgical periodontal therapy (C), an effective 
method of decontamination and treatment (O)?” 
Levels of evidence: Not all evidence is equal and systematic reviews consider the quality of 
evidence before summarising the evidence within a review. This evidence quality is 
determined by the methods used to reducing bias within a study design. Studies with the 
  
highest levels of evidence quality are randomised controlled trials, followed by at least one 
randomised controlled trial on the effectiveness of an intervention. Lower levels of evidence 
are provided by non-randomised controlled trials and single case studies. 
Search bases: Electronic databases Medline (via PubMed and OvidSp) and the Trip database 
were searched by one of the authors (CH) using the following search terms: ‘Lasers and 
Implants’, ‘Lasers in Implantology’, ‘Peri-implantitis and Lasers’, ‘Peri-implantitis and 
decontamination’ and ‘Lasers and Biofilm’. 
Inclusion criteria:  
Literature which examined the effects Laser decontamination in the treatment of peri-
implantitis 
Literature available through the University of Bristol 
Literature from 2000-2014  
Literature in the English language 
Literature from any country provided that it was available in the English language 
Literature which used any study design type 
Both primary and secondary source types were considered 
Literature was included irrespective of outcome  
Exclusion criteria: 
There were no further exclusion criteria were applied due to the limited number of 
publications in this field. 
  
PRISMA flow diagram:  A PRISMA flow diagram of the papers selected for review is shown in 
Figure 1. Forty papers were initially identified and the titles and abstracts of each paper were 
read by a single author (CH). Thirty-four papers were rejected based on their irrelevance to 
this review. Bibliographies of these forty papers were also searched for relevant articles and 
this resulted in two more publications being deemed suitable. Thus, a total of eight articles, 
published between 2005 and 2014 were selected for analysis (Table 1). 
Data capture:  Full-text analysis of all included articles was carried out and information was 
extracted for assessment using data capture sheets which recorded the following data: 
a) Primary research studies: 
- Study, Year 
- Type of study 
- Laser investigated 
- Control 
- Type of Implants 
- No. of Implants/No. of patients 
- Surgical/Non – surgical intervention 
- Adjunctive therapeutics - test and control groups 
- Follow up period 
- BOP 
- Plaque index 
- Clinical attachment level (CAL) 
- Pocket probing depth (PPD) 
- Gingival recession 
- Bone levels 
  
- Wavelength 
- Tip  
- Tip movement 
- Tip angulation 
- Mode 
- Pulse duration 
- Power 
- Time of application 
b) Review papers: 
- Publication, Year and laser investigated 
- Inclusion/Exclusion criteria 
- Studies included in review 
- Type of studies 
- Clinical outcomes/Decontamination potential 
The completed data capture sheets are shown in Tables 2 to 4. 
Bias:  A summary of the risk of bias for all studies included within this review , based upon the 
Cochrane Collaboration’s tool,8 is shown in Table 5. 
 
Results 
The eight studies selected for review included one Case Report,1 one Histological Study,4 one 
Clinical Follow-up,9 one Pilot Study,10 two Randomised Control Trials (RCTs),11,12 one Narrative 
Review,13 and one Systematic Review and Meta-Analysis.7  
  
Primary research papers analysed five Er:YAG lasers and one Diode laser and collected data 
on clinical variables such as bleeding on probing (BOP), plaque index, pocket probing depth 
(PPD), clinical attachment levels (CAL), gingival recession and bone levels. The reviews 
assessed decontamination efficacy of five different lasers and in total investigated eleven 
Er:YAG lasers, seven CO2 lasers, three Nd:YAG lasers, seven GaAIAs diode lasers and one 
Photodynamic treatment (HELBO).  
Laser therapy in peri-implantitis treatment: Primary research mostly utilised Er:YAG lasers 
either as a monotherapy10,12 or adjunctive intervention2,4,8 in the treatment of peri-
implantitis, whilst only one study attempted to observe the efficacy of a Diode laser.11 A total 
number of 175 implants, with a range of different titanium surfaces, were irradiated to 
measure clinical outcomes. All studies collected their final data after 6 months post-
intervention, apart from one study8 where the last follow up was scheduled at 24 months.  
Adjunctive treatment: In most studies4,9,10 plastic curettage was used as a control whilst one 
study11 utilised air-abrasive therapy. Peri- and post-operative medicament adjuncts were 
used within the control groups, including post-surgery antibiotics4 and chlorhexidine 
digluconate 0.2% solution and 0.2% gel.10 One study9 used natural bone mineral and collagen 
membranes within the control group. Additionally, a PERIO-FLOW device was utilised in one 
study.12 
Whilst one study10 did not use any adjunctive therapeutics for the laser test group, one 
utilised the same post-surgery antibiotics as in their control group4 but with the addition of 
2% chlorhexidine gluconate solution whilst two studies9,11 used the same adjuncts for their 
test and control group.  
Surgical versus non-surgical intervention: Two studies4,11 used flap surgery for subgingival 
access, whilst another9 also used a surgical approach but in conjunction with implantoplasty. 
  
A two-stage treatment protocol was implemented in one study2 whereby stage 1 was non-
surgical and stage 2 surgical. Two studies10,12 used a non-surgical approach for 
decontamination.  
Laser power settings: Er:YAG power settings varied between studies, whilst some papers did 
not report on certain variables. Only two studies4,10 used a wavelength of 2.94 µm in contact 
mode. More similarly, two studies10,12 applied a cone-shaped tip with circular tip movement, 
parallel tip angulation and power at 100mJ/pulse but one12 did not report on wavelength and 
pulse duration. One study2 only reported the type of tip, tip movement, angulation and power 
used, making it more difficult to compare to other studies.  
Power settings for the diode laser utilized in one study11 only reported on wavelength, mode, 
power settings and time of application. Only one other study also reported on irradiation 
time.2  
Effects of Er:YAG on BOP: One study2 reported no bleeding after 3 months of laser treatment, 
whilst another12 observed this in only 31% of cases after 6 months post laser therapy. The 
remaining three studies recorded a statistically significant reduction in BOP, whilst one study4 
did not investigate this clinical variable.  
Effects of Er:YAG on plaque index: Three studies9,10,12 recorded non-significant changes in 
plaque levels without significant differences between groups. Two studies2,4 did not report 
on this outcome variable. 
Effects of Er:YAG on CAL: Only two studies by Schwartz et al.9,10 reported on clinical 
attachment levels. The 2012 study9 observed a statistically significant reduction in mean CAL 
values in both groups at 12 months but failed to reach statistical significance after 24 months. 
Between-group comparisons were of no significance. The 2005 study10 however, observed a 
  
statistically significant CAL gain but inter-group comparison did not reach clinical or statistical 
significance.  
Effects of Er:YAG on PPD: Four studies reported significant reductions in pocket probing 
depths, whilst one study4 did not record this variable. One study2 observed a significant 
reduction in PPD after both, stage 1 (non-surgical) and stage 2 (surgical) treatment. Although, 
one study9 reported a significant improvement after 12 months with no notable differences 
between groups, at 24 months, only the control group remained significant. Compared to 
other studies, one study10 observed differences in post- treatment and baseline pocket 
depths, by categorising the pockets into shallow, moderate or deep pockets. Initially deep 
pockets showed significant changes in PPD, whilst moderate pockets showed moderate 
improvements and shallow sites exhibited statistically non-significant changes. One study12 
observed reductions in PPD in both groups but the overall clinical improvement was limited.  
Effects of Er:YAG on gingival recession: Three studies reported mild gingival recession2,9,10 
whilst two studies4,12 did not report on this outcome.  
Effects of Er:YAG on bone levels: The main outcome measures in one study4 was new bone 
formation, collecting data on new bone height (NBH) and new bone-to-implant contact 
(NBIC), by using light microscopy and histometrical analysis. An increase in NBH and NBIC 
were observed in the laser group compared to the curette control group. However, the 
difference between groups did not reach statistical significance.  
Only two studies2,9 adjunctively utilised synthetic or natural bone. One of these2 reported 
bony infill of defects via radiographic evaluation, 6 months after surgery, and no further 
investigations were carried out in light of laser efficacy and new bone formation in this study. 
The other9 also observed an initial increase in bone levels after 12 months but this slightly 
decreased after 24 months.  
  
Whilst three studies reported some degree of increased bone levels, one study12 was the only 
paper observing a loss in bone levels after 6 months, although not clinically significant. One 
study10 did not report on bone levels.  
Effects of diode laser on clinical outcomes: One study11 reported a significant reduction in 
BOP at 3 and 6 months after treatment, with no statistically significant difference between 
groups. Plaque levels saw a continuous reduction between baseline, 3 and 6 months post 
irradiation. Further statistically significant reductions were observed for CAL at both follow 
up time points. PPD showed no statistical difference at 3 and 6 months between groups. PPD 
was decreased at both re-examinations but the second visit did not show any further 
statistically significant improvements.  
Review of clinical outcomes following Er:YAG, CO2 and photodynamic therapy: The review 
study13 observed similar clinical outcomes for CO2 lasers as with Er:YAG lasers, however 
Photodynamic therapy did not reach statistical significance for CAL and PPD was of no clinical 
significance.  
Review of decontamination efficacy following Er:YAG, CO2, GaAIAs diode, Nd:YAG laser 
therapy: One study7 reviewed the decontamination potentials and bactericidal efficacies 
using various laser systems. All lasers exhibited dose dependant decontamination potentials. 
CO2 lasers required higher settings to achieve 100% decontamination compared to Er:YAG. 
However, GaAIAs diode lasers reached near complete elimination of microbes at only 2.5W - 
half of that required for Er:YAG lasers.  
Meta-analysis for Er:YAG laser treatment at the 6-month post-intervention observational 
interval: Outcome measures were deemed to be heterogenic enough to evaluate mean 
outcomes of CAL and PPD by including 3 surgical studies and 1 non-surgical study. Results 
revealed no statistical significance of CA loss after 6 months for the surgical and non-surgical 
  
group and for all studies. Similarly, PPD was also found to be non-significant for surgical and 
non-surgical groups and all studies respectively. No evidence for subgroup differences 
between non-surgical and surgical interventions in CA loss and PPD reduction treatments 
were identified. 
 
Discussion 
The basis of successful treatment of PI disease is a healthy periodontium that requires 
excellent patient education on oral hygiene, constant re-enforcement and motivation. Thus, 
patient compliance is vital after decontamination. Despite that, some studies failed to record 
plaque levels, leading to inconsistencies in results. One study11 reported a decrease in plaque 
levels post-laser treatment, however, this kind of outcome may be confounded by patient’s 
improved oral hygiene regime. It is therefore hard to evaluate whether this was down to laser 
efficacy or patient factors. Regular follow up visits to monitor and maintain oral hygiene is of 
paramount importance. The serious confounding factor of smoking was ignored by all but one 
study12 and did not feature in the exclusion criteria. Furthermore, patient’s medical history 
including systemic disease and medications that could potentially interfere with healing or 
osseointegration, were not taken into consideration either. Only one study12 recorded the 
differences in smoking years and medications between participants but did not exclude 
subjects on the basis of these variables. 
The study designs varied widely, including the use of different surgical and non-surgical 
treatments with the addition of adjunctive therapies between studies as well as within test- 
and control groups. This further complicates the comparison of outcome variables, hence 
relative laser efficacy assessments cannot be made. Not all studies recorded the same clinical 
parameters, including p-values, making a reliable inference impossible.  
  
Small sample sizes in some studies might be skewing outcome data and statistical significance 
cannot be obtained. Power calculations to estimate an acceptable number of patients and/or 
implants needed to obtain a positive therapeutic outcome are required. 
Potential operator bias could not specifically be identified but most studies did not mention 
the number of operators or their skill level, causing possible inter-study discrepancies. 
Most studies selected to treat acute PI, but no universal definition was used throughout the 
studies, potentially shifting some outcomes to look more favourable compared to others. 
Although, some studies reported on suppuration, this was not a consistently reported 
variable.  
One of the biggest inconsistencies between studies was noted in terms of laser settings and 
application. Whilst some variables were left unreported, others varied widely, in spite of 
research showing that energy levels have a significant effect on decontamination of implant 
surfaces.7 Future research needs to address the implementation of protocols and guidance 
for laser application to enable evaluation of the relative effectiveness of lasers on implant 
decontamination and safety. This will become particularly important with the introduction of 
new high pulse repetition rates, increasing the risk of thermally altering the implant surface 
morphology.4 Thus, some current lasers are deemed unsuitable for implant decontamination 
due to reports of cracking, crater formation and melting of titanium surfaces following the 
use of Nd:YAG and holmium-doped:YAG lasers. CO2 lasers are commonly used to irradiate 
implant surfaces, however, there is increased risk of heating the titanium implant and 
surrounding bone.14,15 One study16 investigated the Er:YAG laser for visible irradiation damage 
and reported no changes of titanium under 50 mJ/pulse (energy density 17.7 J/cm2) and 
constant water spray using contact mode. Furthermore, a second study17 investigated 
microstructural changes when irradiation parameters were set to 12.7 J/cm2 and 10 Hz 
  
energy density, whilst cooling the implant surface with water, but no alterations in surface 
structure could be observed either. Thus, research accepts the safe use of Er:YAG laser 
systems for implant surface decontamination.  
A 2008 Cochrane systematic review concluded that only very little reliable evidence currently 
formulates an effective intervention for treating PI, further confirming the need for future 
research, including laser therapy.18 
 
 
 
Conclusions 
The research question “For patients suffering from peri-implantitis, is laser decontamination 
of implant surfaces, compared to traditional non-surgical periodontal therapy, an effective 
method of decontamination and treatment?” has not been answered by this mini-systematic 
review. The use of lasers in dental implant surface treatment requires further high quality 
RCTs to be undertaken and would greatly benefit from prioritising the implementation of 
standards for laser parameters and applications. Most studies focused on Er:YAG lasers, but 
it would be interesting to see future research investigating more treatment outcomes of CO2 
and Diode laser therapies. The use of adjuncts needs to be limited to evaluate true laser 
efficacy. Detailed patient selection, Plaque indices and severity of PI needs to be uniformly 
reported throughout research papers as well as the same outcome variables to allow 
comparison. Positive outcome measures have been obtained after 6 months, suggesting an 
effective initial response to laser decontamination, however, results generally tailed off at 24 
months in the one study that obtained records at this time point. Hence, re-examinations up 
  
to at least one year following treatment with intermittent visits for general implant 
maintenance, oral hygiene and vital patient motivation, need implementing. 
Based on the limited amount of information available, the implications for clinicians at this 
point in time is to follow manufacturers recommended laser settings, whilst using their clinical 
expertise and judgement when carrying out laser therapy in patients with PI.  
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Table 1: The studies included within this review 
 
Study Type of study Laser type Control Follow up period 
Badran et al., 2011 Case report Er:YAG N/a 3 and 6 months 
Takasaki et al., 2006 Histological study Er:YAG Plastic curettes 24 weeks 
Schwarz et al., 2012 Clinical follow up Er:YAG Plastic curettes 12 and 24 months 
Schwarz  et al., 2005 Pilot study Er:YAG Plastic curettes and 
chlorhexidine 
digluconate 0.2% 
3 and 6 months 
Papadopoulos et al., 
2014 
RCT Diode laser Plastic curettes 3 and 6 months 
  
Renvert et al., 2011 RCT Er:YAG Air-abrasive 
therapy 
6 months 
Kotsakis et al., 2014 Systematic Review  
- CO2 laser 
- Er:YAG 
 - Photodynamic 
treatment (HELBO) 
 
- - 
Kamel et al., 2014 Narrative Review  
- GaAIAs diode 
- CO2 
 - Nd:YAG 
- Er:YAG 
 
- - 
 
 
 
 
 
  
  
Figure 1: PRISMA flow diagram of the studies included within the review 
 
 
 
 
 
 
 
  
Table 2: Characteristics of included primary research studies 
Study Type of study Laser 
type 
Control Type of implant No. of 
implants/no. 
of patients 
Surgical/Non-
surgical 
intervention 
Adjunctive 
therapeutics for 
test group 
Adjunctive 
therapeutics for 
control group 
Follow up 
period 
Comments 
Badran et al., 
2011 
Case report Er:YAG N/a Not reported 1 implant/1 
patient 
Stage 1: non-
surgical; 
Stage2: 
surgical 
Surgical ultrasonic 
debridement; bone 
curettes, synthetic 
bone substitute 
(BCP) 
N/a 3 and 6 
months 
 
Takasaki et 
al., 2006 
Histological 
study 
Er:YAG Plastic curettes Sand-blasted large grit 
acid-etched (SLA) 
surface implants (solid 
screw ø 3.3 x 10 mm 
standard plus, ITI® 
Dental implant system, 
Straumann AG, 
Waldenburg, 
Switzerland 
16 
implants/Four 
1-year-old 
beagle dogs 
Peri-implant 
flap surgery 
2% Solution of 
Chlorhexidine 
gluconate; 
Antibiotics for 3 
days post-surgery 
Saline solution 
irrigation; 
Antibiotics for 3 
days post-surgery 
24 weeks Increase in new bone height 
and new bone-to-implant 
contact, compared to the 
control group, although not 
statistically significant 
Schwarz et 
al., 2012 
Clinical follow 
up 
Er:YAG Plastic curettes Implant systems: ANK, 
AST, BRA, CAM, ITI, KSI, 
REP, TSV, XIV, NI*; 
26 implants/ 
24 patients 
Flap surgery; 
Implantoplasty 
Natural bone 
mineral and 
collagen membrane 
cotton pellets; 
sterile saline; 
natural bone 
mineral and 
covered with a 
collagen 
membrane 
12 and 24 
months 
Reductions of BOP, PPD and 
CAL were significant at 12 
months, however, only the 
reduction in BOP remained 
significant after 24 months 
Schwarz  et 
al., 2005 
Pilot study Er:YAG Plastic curettes 
and 
chlorhexidine 
digluconate 
0.2% 
Titanium implants 
(Straumann) Screw 
type; SLA; TPS 
32 implants/ 
20 patients 
Non-surgical No adjuncts used chlorhexidine 
digluconate 0.2%; 
subgingival 
application of CHX 
gel 0.2 % 
3 and 6 
months 
Reductions of BOP, PPD and 
CAL were significant, despite 
unchanged plaque levels 
Papadopoulos 
et al., 2014 
RCT Diode 
laser 
Plastic curettes Titanium Implants 16 
implants/16 
patients 
Flap surgery Plastic curettes, 
sterilized gauzes 
soaked in saline 
Plastic curettes, 
sterilized gauzes 
soaked in saline 
3 and 6 
months 
Reductions in BOP, PPD and 
CAL 6 months after 
treatment; However, diode 
laser irradiation did not deem 
to add any additional benefits 
clinically 
Renvert et al., 
2011 
RCT Er:YAG Air-abrasive 
therapy 
Not reported 100 
implants/42 
patients 
Non-surgical No adjuncts used PERIO-FLOW® 
device 
6 months Reduction of BOP was 
significant, however, 
reduction in PPD was not 
*ANK=Ankylos® (cylindrical screw, microrough surface), Dentsply Friadent, Mannheim Germany; AST=Astra Dental Implant System® (cylindrical screw, microthread, nanotype surface), Astra Tech Dental , Moelndal, Sweden; BRA=Branemark System® 
(cylindrical screw, machined surface), Nobel Biocare AB, Goeteborg, Sweden; CAM=Camlog Screw Line® (cylindrical screw, microrough surface), Camlog Biotechnologies AG, Basel, Switzerland; ITI,ITI® (cylindrical screw, microrough surface), ,Institiute 
Straumann AG, Basel, Switzerland; KSI= KSI Bauer Schraube® (conical screw, machined surface), KSI GmbH, Bad Nauheim, Germany; REP=NobelReplace® (tapered screw, microrough surface), Nobel Biocare AB, Goeteborg, Sweden; TSV=Tapered 
Screw Vent® (tapered screw, microrough surface), Zimmer Dental, Freiburg, Germany; XIV=Xive® (cylindrical screw, microrough surface), Dentsply Friadent, Mannheim, Germany; NI=Non-identifiable implant systems. 
  
  
  
Table 3: Laser settings and applications used in included primary research studies 
 
Study Laser type Wavelength Tip Tip movement Tip angulation Mode Pulse 
duration  
Power Time of 
application 
Badran et al., 
2011 
Er:YAG Not reported Bevelled Not reported 10 - 15 degrees Not 
reported 
Not 
reported 
120 mJ; frequency, 10Hz Irradiated for 60 
seconds 
Takasaki et al., 
2006 
Er:YAG 2.94 µm Chisel sapphire glass 
(P/N 625-8746) with 
rectangular pointed 
head of 1.40 x 0.45 
mm 
Scraping motion 30 - 45 degrees, 
oblique to implant 
surface 
Contact 30 pps 10.0 J/cm2 (62 mJ/pulse); 
frequency 20 Hz 
Not reported 
Schwarz et al., 
2012 
Er:YAG Not reported Not reported Not reported Not reported Not 
reported 
Not 
reported 
11.4 J/cm2, frequency 10 
Hz 
Not reported 
Schwarz et al., 
2005 
Er:YAG 2.94 µm Cone-shaped glass 
fibre 
Circular motion 
from coronal to 
apical 
Parallel to implant Contact 10 pps 12.7 J/cm2 (100mJ/pulse); 
85 mJ/pulse 
Not reported 
Papadopoulos et 
al., 2014 
Diode laser 980 nm Not reported Not reported Not reported Pulsed Not 
reported 
0.8 W; Surface 
irradiated 3 
times with 2 min. 
intervals 
Renvert et al., 
2011 
Er:YAG Not reported Cone-shaped sapphire Semi-circular 
motion around 
the 
circumferential 
pocket area 
Parallel to implant Parallel Not 
reported 
12.71 J/cm2 (100mJ/pulse) Not reported 
 
  
  
Table 4: Outcome measures recorded in included primary research studies 
Study Type of study Laser 
type 
BOP Plaque index Clinical attachment 
level 
Pocket probing depth Gingival recession Bone levels 
Badran et al., 
2011 
Case report Er:YAG No bleeding 
after 3 months 
Not reported Not reported Baseline: 5 -9 mm; 
Reduction after 3 months: 
PPD 2-5 mm, following non-
surgical treatment; 
Additional reduction after 6 
months: PPD  0 - 2 mm post-
augmentation 
Increased by 1 - 2 mm Bony infill 
Takasaki et al., 
2006 
Histological 
study 
Er:YAG Not reported Not reported Not reported Not reported Not reported 61.8 ± 32.7 and 69.7  ± 
15.2% New bone height 
and new bone-to-implant 
contact (mean ±SD, n =4) 
Schwarz et al., 
2012 
Clinical 
follow up 
Er:YAG Reduction after 
12 months: 55.0  
± 28.4%; 
Reduction after 
24 months: 75.0  
± 32.6% 
Non-significant reduction 
after 12 months of 0.42 ± 
1.0 and 0.2 ± 0.6 (mean ± 
SD) after 24 months. No 
significant difference btw. 
groups (p >0.05) 
Reduced after 12 
months: 1.3 ± 1.2 
mm; Reduction after 
24 months: 1.0 ± 2.2 
mm 
Reduction after 12 months: 
1.7 ± 1.2 mm; Reduction 
after 24 months: 1.1  ± 2.2 
mm 
Increased after 12 
months by 0.4 ± 0.2 
mm; Slight decreases 
after 24 months: 0.1  ± 
0.4 mm 
Initially 1 - 3 mm gain  in 
80% of patients, followed 
by slight loss after 24 
months 
Schwarz et al., 
2005 
Pilot study Er:YAG 30% after 3 
months; 31% 
after 6 months 
compared to 
83% at baseline 
Non-significant reduction 
after 3 months from 1.1 ± 
0.5 (baseline) to 1.0 ± 0.6 
follow by a slight increase 
after 6 months to 1.1 ± 0.4 
Mean gain after 6 
months of 0.6 ± 0.3 
mm in moderately 
deep sites; in deep 
sites 0.9  ± 0.5 mm; 
shallow sites non-
significant 
Reduction after 3 months 
and 6 months of 0.8 ± 0.1 
mm; 
Non-significant 
increase after 3 and 6 
months of 0.1  ± 0.1 
mm 
Not reported 
Papadopoulos 
et al., 2014 
RCT Diode 
laser 
Significant 
reduction at 3 
and 6 months 
4.2% reduction of plaque 
levels after 3 months with 
additional reduction of 
5.4% after 6 months 
Reduction of 0.71 
mm after 3 months, 
with a further 
reduction of 0.8 mm 
after 6 months. 
Reduction after 3 months of 
1.38 mm; Reduction after 6 
months of  1.48 mm 
Not reported Not reported 
Renvert et al., 
2011 
RCT Er:YAG No evidence of 
bleeding in 31% 
of implants 
treated after 6 
months 
Non-significant changes in 
visible plaque between 
groups at 6 and 12 weeks 
and 6 months; Slight 
reduction after 6 months 
in control group (p <0.05) 
Not reported Reduction of 0.8 mm (SD ± 
0.5) after 6 months with a 
reduction of > 1.0 mm in 
25% of subjects 
Not reported Reduction of 0.3 mm (SD 
+ 0.9) after 6 months 
 
  
  
Table 4: Included review articles and their corresponding publications, laser investigations and overall findings 
Review article Type of review Lasers 
investigated 
No. of 
studies 
included 
Inclusion criteria/Exclusion 
criteria 
Studies included in 
review 
Lasers 
investigated 
Type of study Comments 
Kotsakis et al., 
2014 
Systematic 
Review; 
Meta-analysis 
Er:YAG; CO2 
laser; 
Photodynamic 
therapy 
6 Inclusion criteria: 
- English language 
Human studies 
- Prospective, controlled, 
clinical studies reporting 
data from at least 10 
patients 
- Use of Laser therapy as 
monotherapy or as an 
adjunct in the treatment 
of peri-implantitis 
- Report of clinical indexes 
of peri-implant disease, 
including CAL and PD 
- Follow-up of at least 6-
months following 
treatment 
 
Exclusion criteria: 
- Not stated 
Deppe  et al., 2007 Carbon dioxide 
laser 
Prospective 
clinical study 
- Significant reduction in PD; CAL only significantly 
reduced in conjunction with adjunctive bone 
augmentation; 
- Halting CAL was significantly more successful, 
compared to conventional treatment, when 
combined with soft tissue resection 
Schwarz  et al., 
2012  
Er:YAG RCT - Statistically significant reduction in PD at 12 
months but not significant after 24 months; 
- BOP and CAL significantly reduced at 12 months, 
however, only BOP remained significant after 24 
months 
Renvert  et al., 
2011 
Er:YAG RCT - No significant reduction in PD but a significant 
reduction in BOP, 6 months post-treatment 
Schwarz  et al., 
2006  
Er:YAG  RCT  - Significant reduction in CAL and PD, 6 months 
post-treatment but the reduction is not 
maintained after 12 months (mean reduction in 
PD and CAL: <1mm) 
- Reduction in BOP was significantly greater 
compared to baseline 
Schwarz  et al., 
2005 
Er:YAG RCT - Same findings as Schwarz  et al., 2006 
Schaer  et al., 2013 Photodynamic 
treatment 
(HELBO) 
RCT - Reduction in CAL was statistically not significant; 
Significant reductions in PD after 6 months, but 
magnitude of reduction was of no clinical 
significance (0.36mm) 
 
  
  
  
Table 4 (continued) 
Review 
article 
Type of 
review 
Lasers 
investigated 
No. of 
studies 
included 
Inclusion 
criteria/Exclusion 
criteria 
Studies included 
in review 
Lasers 
investigated 
Type of 
study 
Comments 
Kamel 
et al., 
2014 
Narrative 
Review 
Nd:YAG; 
Er:YAG; CO2 
and Diode 
lasers 
18 Inclusion criteria: 
- English 
language 
- Published within 
the past 20 years, 
current to 8 
February 2012 
 
Exclusion criteria: 
- Clinical studies 
- Case reports 
- Case series 
- Animal studies 
- Review articles 
 
Goncalves  et al., 
2010  
GaAIAs diode 
laser; Nd:YAG 
 
 
 
 
 
 
 
 
All in 
vitro 
studies 
 
 
 
 
 
 
 
 
  
Decontamination potentials: 
Er:YAG: 
- Er:YAG exhibited dose-dependent decontamination, ranging from 59% 
following irradiation with 80 mJ/pulse at 5 Hz (Tosun  et al., 2012) to 99.94% 
with 120 mJ/pulse at 10 Hz (Kreisler  et al., 2002); 
- Increased decontamination was observed in very short pulse (VSP) mode at 
any given power, compared to short pulse (SP) mode. 
- However, 100% decontamination could only be consistently achieved at 90 
mJ/pulse at 10 Hz in SP mode (Tosun et al., 2012). 
 
Carbon dioxide laser: 
- CO2 lasers exhibited a dose-dependent bactericidal efficacy with values 
ranging from 68% with 2-4 W (10 ms/pulse, 20 Hz) to 100% with 6 W (20 
ms/pulse, 20 Hz) (Tosun  et al., 2012). 
- Streptococcus sanguinis shows greater irradiation resistance than 
Porphyromonas gingivalis when exposed to 15 to 40 J (Kato  et al., 1998); 
(Hauser-Gerspach  et al., 2010). 
 
 
GaAIAs diode laser: 
- Dose-dependent decontamination efficacy with decontamination of 45% at 
0.5 W to 99.9% at 2.5 W (Kreisler  et al., 2003) 
- Some studies reported that 100% decontamination cannot be achieved 
(Kreisler et al., 2003); (Sennhenn-Kirchner et al., 2007); others reported 100% 
decontamination at powers as low as 1 W (Tosun  et al., 2012)  and bacterial 
reductions ranging between 94.67 and 100% (Sennhenn-Kirchner et al., 2007). 
Enterococcus faecalis and S. sanguinis exhibited increased irradiation resistance 
to GaAIAs diode lasers, compared to P. gingivalis (Goncalves et al., 2010); 
(Hauser-Gerspach et al., 2010). 
 
Nd:YAG laser: 
- Powers ranging from 0.3 to 3.0 W exhibited incomplete elimination of 
microbes in some studies (Giannini et al., 2006); (Block et al., 1992); others 
showed 100% decontamination using 3.0 W (Goncalves  et al., 2010). 
- P. gingivalis was easier to eliminate compared to E. faecalis (Goncalves et al., 
2010). 
 
Haas  et al., 
1997  
GaAIAs diode 
laser 
 
 
Kato et al., 1998 
  
Carbon dioxide 
laser 
 
Mouhyi  et al., 
1998  
Carbon dioxide 
laser 
 
 
Mouhyi  et al., 
2000 
  
Carbon dioxide 
laser 
 
Kreisler et al., 
2002  
Er:YAG 
 
Kreisler et al.,  
2003  
GaAIAs diode 
laser 
 
Matsuyama  et 
al., 2003  
Er:YAG 
 
Shibli  et al., 
2004 
  
Carbon dioxide 
laser 
 
Schwarz  et al., 
2005  
Er:YAG 
 
 
Nd:YAG 
  
Giannini  et al., 
2006 
  
 
Schwarz  et al., 
2006  
Er:YAG 
 
Quaranta  et al., 
2009  
Er:YAG 
 
 
Sennhenn-
Kirchner  et al., 
2009 
  
Er:YAG; GaAIAs 
diode laser 
 
Tosun  et al., 
2012  
Er:YAG; Carbon 
dioxide laser; 
GaAIAs diode 
laser 
 
Block  et al., 
1992  
Nd:YAG 
 
Hauser-Gerspach 
et al., 2010  
Carbon dioxide 
laser; GaAIAs 
diode laser 
 
 
Sennhenn-
Kirchner  et al., 
2007 
  
GaAIAs diode 
laser 
 
  
Table 5: Summary of risk of bias within the included studies, based upon the Cochrane Collaboration’s tool.5 
Study Type of study        
Badran et al., 
2011 
Case report N/a N/a N/a N/a N/a N/a High 
Takasaki et 
al., 2006 
Histological 
study 
N/a N/a N/a N/a N/a N/a High 
Schwarz et al., 
2012 
Clinical follow 
up 
N/a N/a N/a N/a N/a N/a High 
Schwarz  et 
al., 2005 
Pilot study N/a N/a N/a N/a N/a N/a High 
Papadopoulos 
et al., 2014 
RCT Low Unclear Low Unclear High Unclear Unclear 
Renvert et al., 
2011 
RCT Low Unclear Low Unclear Low Low Unclear 
Kotsakis et 
al., 2014 
Systematic 
Review 
N/a N/a N/a N/a N/a N/a Low 
Kamel et al., 
2014 
Narrative 
Review 
N/a N/a N/a N/a N/a N/a Low 
  
Random 
Sequence 
Generation 
Allocation 
Concealment 
Blinding of 
Participants 
and Personnel 
Blinding of 
Outcome 
Assessment 
Incomplete 
Outcome Data 
Selective 
Reporting 
Other Bias 
 
